Article
Sarepta faces another gene therapy hiccup as Regenxbio sues over Jim Wilson's patent
Rating:
0.0
Views:
53
Likes:
1
Library:
1
It turns out a regulatory delay isn't the only bump on Sarepta's road to gene therapy glory. The biotech is being sued by Regenxbio, which is alleging that its slate of gene therapy programs, including two for Duchenne muscular dystrophy and limb-girdle muscular dystrophy infringes on a patent originally owned
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value